DENVER: Mydecine Innovations Group Inc. has formed a special committee to evaluate a number of options to increase shareholders value, a news release said. Topics that the special committee will discuss include, but limited to, a potential spin out of certain company assets. Currently, the company owns and operates a number of growing US assets…